Logo image of IFBD

INFOBIRD CO LTD (IFBD) Stock Fundamental Analysis

NASDAQ:IFBD - Nasdaq - KYG477243003 - Common Stock - Currency: USD

1.095  +0 (+0.39%)

Fundamental Rating

2

Overall IFBD gets a fundamental rating of 2 out of 10. We evaluated IFBD against 282 industry peers in the Software industry. IFBD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IFBD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IFBD has reported negative net income.
IFBD had a negative operating cash flow in the past year.
IFBD had negative earnings in 4 of the past 5 years.
IFBD had negative operating cash flow in 4 of the past 5 years.
IFBD Yearly Net Income VS EBIT VS OCF VS FCFIFBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

The Return On Assets of IFBD (-2.85%) is comparable to the rest of the industry.
IFBD's Return On Equity of -3.24% is fine compared to the rest of the industry. IFBD outperforms 62.41% of its industry peers.
Industry RankSector Rank
ROA -2.85%
ROE -3.24%
ROIC N/A
ROA(3y)-33.03%
ROA(5y)-24.55%
ROE(3y)-79.95%
ROE(5y)-56.26%
ROIC(3y)N/A
ROIC(5y)N/A
IFBD Yearly ROA, ROE, ROICIFBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

IFBD has a worse Gross Margin (41.21%) than 74.82% of its industry peers.
In the last couple of years the Gross Margin of IFBD has declined.
IFBD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.57%
GM growth 5Y-6.03%
IFBD Yearly Profit, Operating, Gross MarginsIFBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

IFBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IFBD has more shares outstanding
IFBD has more shares outstanding than it did 5 years ago.
There is no outstanding debt for IFBD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IFBD Yearly Shares OutstandingIFBD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
IFBD Yearly Total Debt VS Total AssetsIFBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that IFBD is in the distress zone and has some risk of bankruptcy.
IFBD's Altman-Z score of 0.13 is on the low side compared to the rest of the industry. IFBD is outperformed by 70.57% of its industry peers.
There is no outstanding debt for IFBD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC11.04%
IFBD Yearly LT Debt VS Equity VS FCFIFBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

IFBD has a Current Ratio of 2.63. This indicates that IFBD is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.63, IFBD is doing good in the industry, outperforming 72.34% of the companies in the same industry.
A Quick Ratio of 2.63 indicates that IFBD has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.63, IFBD is in the better half of the industry, outperforming 73.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.63
IFBD Yearly Current Assets VS Current LiabilitesIFBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.36% over the past year.
IFBD shows a strong growth in Revenue. In the last year, the Revenue has grown by 413.54%.
IFBD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -39.84% yearly.
EPS 1Y (TTM)99.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.95%
Revenue 1Y (TTM)413.54%
Revenue growth 3Y-46.97%
Revenue growth 5Y-39.84%
Sales Q2Q%406.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IFBD Yearly Revenue VS EstimatesIFBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IFBD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IFBD Price Earnings VS Forward Price EarningsIFBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IFBD Per share dataIFBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IFBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INFOBIRD CO LTD

NASDAQ:IFBD (7/22/2025, 8:20:00 PM)

1.095

+0 (+0.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-10 2025-04-10
Earnings (Next)N/A N/A
Inst Owners0.14%
Inst Owner Change-0.28%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.97M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.24
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB 3.84
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0.18
BVpS7.91
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.85%
ROE -3.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.21%
FCFM N/A
ROA(3y)-33.03%
ROA(5y)-24.55%
ROE(3y)-79.95%
ROE(5y)-56.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.57%
GM growth 5Y-6.03%
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 680.35%
Cap/Sales 53.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.63
Altman-Z 0.13
F-Score3
WACC11.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)413.54%
Revenue growth 3Y-46.97%
Revenue growth 5Y-39.84%
Sales Q2Q%406.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.18%
OCF growth 3YN/A
OCF growth 5YN/A